Literature DB >> 17725364

Development of a renal microchip for in vitro distal tubule models.

Régis Baudoin1, Laurent Griscom, Matthieu Monge, Cécile Legallais, Eric Leclerc.   

Abstract

Current developments in tissue engineering and microtechnology fields have allowed the proposal of pertinent tools, microchips, to investigate in vitro toxicity. In the framework of the proposed REACH European directive and the 3R recommendations, the purpose of these microtools is to mimic organs in vitro to refine in vitro culture models and to ultimately reduce animal testing. The microchip consists of functional living cell microchambers interconnected by a microfluidic network that allows continuous cell feeding and waste removal controls by fluid microflow. To validate this approach, Madin Darby Canine Kidney (MDCK) cells were cultivated inside a polydimethylsiloxane microchip. To assess the cell proliferation and feeding, the number of inoculated cells varied from 5 to 10 x 10(5) cells/microchip (corresponding roughly to 2.5 to 5 x 10(5) cells/cm2) and from four flow rates 0, 10, 25, and 50 microL/min were tested. Morphological observations have shown successful cell attachment and proliferation inside the microchips. The best flow rate appears to be 10 microL/min with which the cell population was multiplied by about 2.2 +/- 0.1 after 4 days of culture, including 3 days of perfusion (in comparison to 1.7 +/- 0.2 at 25 microL/min). At 10 microL/min flow rate, maximal cell population reached about 2.1 +/- 0.2 x 10(6) (corresponding to 7 +/- 0.7 x 10(7) cells/cm(3)). The viability, assessed by trypan blue and lactate deshydrogenase measurements, was found to be above 90% in all experiments. At 10 microL/min, glucose monitoring indicated a cell consumption of 16 +/- 2 microg/h/10(6) cells, whereas the glutamine metabolism was demonstrated with the production of NH3 by the cells about 0.8 +/- 0.4 micromol/day/10(6) cells. Augmentation of the flow rate appeared to increase the glucose consumption and the NH3 production by about 1.5- to 2-fold, in agreement with the tendencies reported in the literature. As a basic chronic toxicity assessment in the microchips, 5 mM and 10 mM ammonium chloride loadings, supplemented in the culture media, at 0, 10, and 25 micaroL/min flow rates were performed. At 10 microL/min, a reduction of 35% of the growth ratio with 5 mM and of 50% at 10 mM was found, whereas at 25 microL/min, a reduction of 10% with 5 mM and of 30% at 10 mM was obtained. Ammonium chloride contributed to increase the glucose consumption and to reduce the NH3 production. The microchip advantages, high surface/volume ratio, and dynamic loadings, coupled with the concordance between the present and literature results dealing with ammonia/ammonium effects on MDCK illustrate the potential of our microchip for wider in vitro chronic toxicity investigations.

Entities:  

Mesh:

Year:  2007        PMID: 17725364     DOI: 10.1021/bp0603513

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  27 in total

1.  Reconstituting organ-level lung functions on a chip.

Authors:  Dongeun Huh; Benjamin D Matthews; Akiko Mammoto; Martín Montoya-Zavala; Hong Yuan Hsin; Donald E Ingber
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

2.  Microfabrication of human organs-on-chips.

Authors:  Dongeun Huh; Hyun Jung Kim; Jacob P Fraser; Daniel E Shea; Mohammed Khan; Anthony Bahinski; Geraldine A Hamilton; Donald E Ingber
Journal:  Nat Protoc       Date:  2013-10-10       Impact factor: 13.491

3.  Long-term flow through human intestinal organoids with the gut organoid flow chip (GOFlowChip).

Authors:  Barkan Sidar; Brittany R Jenkins; Sha Huang; Jason R Spence; Seth T Walk; James N Wilking
Journal:  Lab Chip       Date:  2019-10-09       Impact factor: 6.799

Review 4.  Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age.

Authors:  Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

5.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 6.  Organ-on-a-chip engineering: Toward bridging the gap between lab and industry.

Authors:  Qasem Ramadan; Mohammed Zourob
Journal:  Biomicrofluidics       Date:  2020-07-14       Impact factor: 2.800

Review 7.  From 3D cell culture to organs-on-chips.

Authors:  Dongeun Huh; Geraldine A Hamilton; Donald E Ingber
Journal:  Trends Cell Biol       Date:  2011-10-25       Impact factor: 20.808

8.  Microfluidics meets metabolomics to reveal the impact of Campylobacter jejuni infection on biochemical pathways.

Authors:  Ninell P Mortensen; Kelly A Mercier; Susan McRitchie; Tammy B Cavallo; Wimal Pathmasiri; Delisha Stewart; Susan J Sumner
Journal:  Biomed Microdevices       Date:  2016-06       Impact factor: 2.838

9.  Modular microfluidic system as a model of cystic fibrosis airways.

Authors:  M Skolimowski; M Weiss Nielsen; F Abeille; P Skafte-Pedersen; D Sabourin; A Fercher; D Papkovsky; S Molin; R Taboryski; C Sternberg; M Dufva; O Geschke; J Emnéus
Journal:  Biomicrofluidics       Date:  2012-08-02       Impact factor: 2.800

Review 10.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.